Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study
Precision Radiation Oncology · 2025-03 · 9 (1) · 54-60
DOI: 10.1002/pro6.70002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Radiation Oncology, online erschienen am 03.03.2025. Verfasst von Yuenan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapeutic Radiology Yale University School of Medicine New Haven Connecticut USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Colorectal cancer (CRC) is one of the leading causes of cancer‐related death worldwide. Dihydroartemisinin (DHA) is an anti‐malaria agent and recent evidence indicates a broad anti‐cancer activity. Radiotherapy (RT) is the cornerstone of cancer treatment and often has synergistic effects when combined with chemotherapy or targeted therapy. We aim to investigate whether synergistic effect exists for RT combined with DHA in a preliminary animal study of CRC treatment.
Methods
Twenty‐four BALB/c nude mice were subcutaneously injected with 5.0 × 10 6 cells of the murine CRC cell line CT26. When tumor xenografts were formed (∼ 100 mm 3 ), mice were randomly allocated into four groups (n = 6 per group) and the tumor‐bearing mice were intra‐abdominally injected at Day 7, 9, 11 with PBS (control), 6Gy irradiation (RT), DHA (50mg/Kg), and DHA with irradiation (DHA+RT). All RT was performed on a medical linear accelerator using collimated anterior posterior 6MV photon beam conformal to tumor xenografts. The tumor volume was measured using an electronic caliper and was calculated based on the length (L) and the width of the tumor using the formula V = (L x W 2 )/2. Tumor weight was also measured after mice sacrificed. Histological assay was conducted, including using gammaH2AX for DNA double strand breaks (DSB) analysis.
Results
The tumor weight was 2.4±0.8g, 2.5±0.6g, 0.4±0.2g, and 0.4±0.1g for the control, DHA, RT, and DHA+RT groups, respectively. Significant difference was observed between the control and RT groups, and between the control and DHA+RT groups (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Therapeutic Radiology Yale University School of Medicine New Haven Connecticut USA.
- Department of Medical Oncology Peking University Shenzhen Hospital Shenzhen P. R. China.
- Department of Pharmaceutical Sciences Health Science Center Shenzhen University Shenzhen P. R. China.
ORCID-Profile: Yuenan Wang, Fada Guan
Zitieren
APA
Wang, Y., Yang, X., Xiao, H., Guan, F., & Aneja, S. (2025). Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study. Precision Radiation Oncology, 9(1), 54-60. https://doi.org/10.1002/pro6.70002
Vancouver
Wang Y, Yang X, Xiao H, Guan F, Aneja S. Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study. Precision Radiation Oncology. 2025;9(1):54-60. doi:10.1002/pro6.70002
BibTeX
@article{Wang2025,
author = {Wang, Yuenan and Yang, Xiaodong and Xiao, Haitao and Guan, Fada and Aneja, Sanjay},
title = {Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study},
journal = {Precision Radiation Oncology},
year = {2025},
volume = {9},
number = {1},
pages = {54--60},
doi = {10.1002/pro6.70002}
}
EUVIMED